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Abstract
This paper provides details on the necessary steps to assess and control data
in genome wide association studies (GWAS) using genotype information on a
large number of genetic markers for large number of individuals. Due to varied
study designs and genotyping platforms between multiple sites/projects as well
as potential genotyping errors, it is important to ensure high quality data.
Scripts and directions are provided to facilitate others in this process.
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Introduction
Biases and errors can lead to erroneous associations in case- 
control association tests. Quality control (QC) that removes mark-
ers and individuals from a study that may introduce these biases 
can greatly increase the accuracy of findings. There are many 
examples of best practices for GWAS QC1,2. This paper describes 
some standard QC steps and also provides links to automated 
scripts to perform QC making the process easier and easily repro-
ducible. Standard tools such as PLINK3 and SMARTPCA4,5 are 
called by the scripts.
Due to the need for reproducibility in science, automated pipelines 
that can be used to repeat computational experiments and save rel-
evant parameters is extremely important. Done step-by-step, the 
QC process can be quite lengthy (about 8 hours for an expert and 
almost certainly longer for a novice and/or someone with limited 
computational resources according to Anderson et al.1) and difficult 
to repeat exactly. Here we present scripts that perform automated 
GWAS QC using a parameter file that can be saved to redo the 
process and save human time. A log file is produced that summa-
rizes the process to easily compare different QC parameters and 
their effects on the data.
Methods
Implementation
QC steps implemented in this pipeline. The steps automated here 
mostly follow the notes on QC6 developed by MikeWeale and 
also calls some R7 scripts described in his notes during the QC 
pipeline. It is assumed that input files are already in PLINK format. 
Figure 1 shows a complete QC pipeline that includes combining 
data from multiple chromosomes and studies and two portions 
of the QC pipeline. There are two scripts, QC.py which takes 
advantage of PLINK calls and also PCA.py that does principal 
component analysis to investigate population stratification.
1. Gender mismatches
     The optional first step in the automated pipeline is a check 
for gender mismatch using the PLINK ‘-- check-sex’ com-
mand. This command compares the sex reported in the .fam 
file and the sex imputed from the X chromosome inbreed-
ing coefficients. This step automatically removes individuals 
where problems are identified. The step was made 
optional because our dataset of interest is matched with 
phenotype/clinical data of higher accuracy. This step can be 
turned off using the parameter file as described below in the 
Operation section.
2. Thresholds
     The next steps in this pipeline include checking and apply-
ing thresholds for minor allele frequency (MAF), missing-
ness for each individual, and missingness of markers. Minor 
allele frequency filtering is important because rare genotypes 
will not show up as often and thus will have less evidence 
in a GWAS and the calls will be less certain and it is also 
difficult to detect associations with them. Missingness can 
lead to false associations if it is non-random with respect to 
phenotypes or genotypes. Single nucleotide polymorphism 
Figure 1. Full QC Pipeline.
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(SNP) missingness is the complement to individual missing-
ness and is correlated with SNP quality from the original 
genotyping assay. Missingness is investigated using PLINK 
‘--missing’ and plots are generated as described by Weale6. 
All the plots that are generated during the process are com-
pressed at the end in order to facilitate downloading them 
when the process is performed remotely on a cluster.
     In order to attempt to retain the largest number of mark-
ers and individuals that pass QC there is an option to do a 
two-tiered missingness by individuals filtering. We noticed 
during testing that this could sometimes lead to final data-
sets with higher numbers of both. If a value is supplied to 
the #MIND1 parameter (described below in Operations), 
then this (expectedly non-stringent) threshold for PLINK 
‘--mind’ is used first and the more stringent #MIND is 
applied in the same step as the PLINK ‘--geno’ and ‘--maf’ 
thresholds for missingness of markers and minor allele 
frequency, respectively. If a major reduction in the number 
of markers or individuals is found during these steps, 
investigation of the generated graphs can help adjust these 
thresholds. See notes6 for more information.
     Some reasoning8 suggests that a minor allele frequency 
threshold should be set to 10/n where n is the number of 
markers. The #MAF parameter can be set to ‘na’ which will 
use 10/n as a threshold or a threshold value can be explicitly 
given, such as ‘.01’.
3.  Heterozygosity
     Individuals resulting from random mating within a popu-
lation should have predictable heterozygosity (H) values. 
H is a measure of the number of loci in an individual that 
are heterozygous. Departure from expected H values can 
signify DNA quality issues (high H) or samples from a dif-
ferent population (low H). This step can be turned off by 
not supplying the ‘#HET’ parameter in the parameter file. 
As long as the parameter is listed, this step will be done. 
H and the inversely related F (Method-of moments F coef-
ficient estimate) are investigated using PLINK ‘--het’. F is 
calculated as the ([observed homozygous count] - [expected 
count])/([total observations] - [expected count])) where the 
expected count is calculated from an imputed MAF. A histo-
gram of F values is generated for manual investigation.
     If values for ‘#FMIN’ and ‘#FMAX’ are supplied in the 
parameter file then samples with an F value below ‘#FMIN’ 
and above ‘#FMAX’ are removed. If these values are not sup-
plied then samples above or below three standard deviations 
of the mean H are removed, as suggested be Anderson et al.1.
4. Hardy-Weinberg equilibrium (HWE)
     Markers out of HWE can indicate that there were genotyping 
errors. However, a strong association signal can also result 
in deviations from HWE. So here only variants from con-
trol samples are checked for deviations from HWE. PLINK 
‘--hardy’ is used to generate HWE p-values and a Q-Q 
plot of the log-P-values of the markers for the controls is 
generated for manual investigation. A p-value threshold is 
supplied in the parameter file to remove markers with a p-
value lower than expected.
5. Cryptic relatedness
     Cryptic relatedness (CR) is when pairs of individuals are 
closely related and can lead to false positive or negative 
correlations when subjects are treated as independent. The 
PLINK ‘--genome’ command can estimate relatedness, but 
is quite slow when there are a large number of markers in a 
dataset. Therefore, markers in high linkage disequilibrium 
(LD) are removed first to thin the data. This is done using 
PLINK ‘--indep-pairwise’ with parameters suggested by 
Weale6. This creates a pruned data set that contains mark-
ers with a minimal LD (which is caused by limited recom-
bination occurring between two or more loci and results in 
a non-random association between the loci). Furthermore, 
only assayed markers are used in this step (i.e. not imputed 
markers). Using a pruned data set is advantages because CR 
methods work best when no LD is assumed between markers 
and it also reduces the input size and in turn greatly reduces 
the computation time.
     PLINK ‘--genome’ estimates relatedness of all pairs of 
samples and reports identify by decent (IBD, a measure of 
whether identical regions of two genomes were inherited 
from the same ancestry) in the PI_HAT (actually, propor-
tional IBD, i.e. P(IBD=2) + 0.5*P(IBD=1)) column of the 
result file. A PI_HAT value close to 1 would indicate a dupli-
cate sample. The threshold 0.1875 represents the half-way 
point between 2nd and 3rd degree relatives and is a common 
cut-off to use. Of each pair of related individuals, the one 
with the greater proportion of missing SNPs is dropped from 
the final dataset.
6. Principal component analysis (PCA)
     Generally, PCA transforms a data matrix (such as a GWAS 
n x m matrix where n in is the number of individuals and 
m is the number of markers and each element in the matrix 
represents the scaled genotype for the particular individual 
at that particular marker) so that the successive principal 
components are not correlated. The number of PCs is less 
than or at most equal to the original number of columns 
and the first PC explains the largest variance in the geno-
type data. Traditionally, PCA is used to (1) screen the study 
population for heterogeneous ethnic backgrounds and (2) to 
correct for potential population stratification (the difference 
of allele frequencies in ancestral subpopulations). It can be 
seen in Figure 2 where HapMap9,10 data with individuals 
with known ancestry are included in the PCA, when plotting 
the first two PCs subpopulations cluster together. HapMap is 
an international project that aims to identify genetic similari-
ties and differences between populations.
     As with the cryptic relatedness step, a thinned dataset 
created with PLINK and starting from assayed markers only 
is used to calculate PCs. The SMARTPCA tool is used to 
calculate PCs from this thinned dataset and identify outliers 
for removal. The PCs can then be used for further corrections 
in analysis models.
Page 3 of 9
F1000Research 2016, 5:1889 Last updated: 25 DEC 2016
Data Formats. The input GWAS data are expected to be in PLINK 
bfile format. The input data will have three files associated to it with 
.bed, .bim, and .fam file extensions. The .bed file is a binary file that 
contains the genotype information for all individuals (https://www.
cog-genomics.org/plink2/formats#bed). The .bim file is a mapping 
file giving information on each marker (https://www.cog-genomics.
org/plink2/formats#bim). The .fam file gives information on each 
individual (https://www.cog-genomics.org/plink2/formats#fam). 
This pipeline utilizes information that was not provided in the 
original PLINK files and therefore the phenotype is always pro-
vided in an alternate phenotype file. PLINK ‘–pheno’ is used to 
provide the phenotype file and PLINK ‘–pheno-name’ is used to 
provide the phenotype name which also corresponds to the header 
of the column in the phenotype file. The first two columns in the 
phenotype file must have the column headers ‘FID’ and ‘IID’ 
respectively. ‘FID’ is the family ID or ‘0’ if not used and ‘IID’ is the 
individual ID that corresponds to the ‘IID’ values in the .fam file 
(https://www.cog-genomics.org/plink2/input#pheno).
Operation
System. The pipeline was tested on STATGEN, a Dell PowerEdge 
R520 server with two Intel Xeon E5-2470 CPUs (32 cores at 
2.3GHz), 24TB of storage in a RAID6 array with two drive fault 
tolerance, and 128GB of RAM. The operating system is Ubuntu 
Server 14.04 LTS 64-bit edition.
Required software. The automated pipeline is written in Python 
and calls Rscript, PLINK, and SMARTPCA. The versions used for 
building and testing are the following,
1. Python - Python 2.7.6
2. Rscript - R scripting front-end version 3.2.2
3. PLINK - PLINK v1.90b3x 64-bit
4. SMARTPCA – smartpca version 13050
Parameter files. Example parameter files are shown in Figure 3. 
The QC.py and PCA.py scripts read in parameters and names them 
based on the word following the ‘#’ and gives that parameter the 
value following the white space on the same line. The line num-
bers in the figure are not a part of the parameter file (i.e. each line 
starts with ‘#’). The parameters and values are stored in a python 
dictionary, so order and extra parameters do not matter. However, 
the exact name and case of the parameters are important for the 
scripts to correctly function. The parameters described here are 
ordered by the line number given in the qc_params.txt file in 
Figure 3a. The parameters with the same name in the pca_params.
txt file in Figure 3b have the same meaning.
  1.  WORK – path to the working directory where all generated 
files will be written
  2.  RPATH – path to where Rscript is located, or name if in a 
known path
  3.  PLINKPATH – path to the PLINK executable, or name if 
in a known path
  4. INPUT – input file in PLINK bfile format
  5.  SCRIPTS – path to directory in which the helper scripts 
called by the pipeline live
  6. MAF – minor allele frequency threshold
  7. MIND – individual missingness threshold
  8. GENO – marker missingness threshold
  9. HWE – Hardy-Weinberg threshold
10. PI_HAT – IDB threshold
11.  SEX – if value is equal to ‘yes’ then a PLINK sex check is 
performed, otherwise it is not
12.  ASSAYED – location of file that includes names of all 
Figure 2. PCA with HapMap data included.
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assayed markers in a study to ensure that imputed SNPs 
are not used for some QC steps
13.  MIND1 – an optional, first tier (non-stringent) individual 
missingness threshold
14.  HET – if this parameter is included then the Heterozygosity 
step is performed (NOTE since ‘#FMIN’ and ‘#FMAX’ 
are not given, this parameter file will result in the removal 
of markers with an H value +/- 3 standard deviations)
15.  CLEAN – will result in the removal of intermediate files 
and final PLINK finals to be named ‘final’ 
16.  PHENO – the name of the phenotype that will be inves-
tigated during analysis. Some QC steps vary based on 
whether or not an individual is case, control, or undefined.
17.  PFILE – the files in which the phenotype is given formatted 
in the proper PLINK format with FID, IID, pheno1 column 
headers where FID is the family ID (commonly 0 if rela-
tions not known), the individual’s ID, and the phenotype 
value encoded as 1=unaffected (control) and 2=affected 
(case).
18.  SMARTPCA (line #2 in pca_params.txt and not in 
qc_params.txt) – link to the smartpca executable.
Running scripts and results 
1. QC.py
     Once the parameters and values are correctly written to 
the parameter file, the script is executed by calling the 
parameter file as a command line argument as follows,
                                   python QC.py qc_params.txt
     The QC steps are performed as described in the Implementa-
tion section and after each step a count is retrieved for the 
number of individuals or markers removed in each step. A 
log file is written (final_QC.log). All of the parameters from 
qc_params.txt are first written to the log file to ensure the 
process can be duplicated. Then the number of individuals/
markers removed during each step are recorded along with 
the running total of how many individuals and markers are 
left in the dataset. This allows for easy comparison of the 
overall effects of different parameter settings. If ‘#CLEAN’ 
is set then the final QC dataset is in PLINK format and 
named ‘final.bed’, ‘final.bim’, and ‘final.fam’. There will 
be an archived file ‘final_graphs.tgz’ containing the files 
missing.png, het.png, hwe.png, and relate.png, created in 
the thresholds, hetereozygosity, and HWE steps above for 
manual inspection in case parameters need to be adjusted 
and QC redone.
2. PCA.py
     Once the parameters and values are correctly written to 
the parameter file, the scripts is executed by calling the 
parameter file as a command line argument as follows,
                       python PCA.py pca_params.txt
     The data thinning is carried out in PLINK, the input file for 
SMARTPCA is automatically generated, and then SMART-
PCA is called to calculate the PCs. If the analysis is being 
done in R, then the ‘smartpca.evec’ file can be read in and 
merged to exclude individuals in which PCs were not cal-
culated (i.e. outliers). PCA.py also generates a file called 
‘remove.txt’ in PLINK format with an FID (all marked ‘0’) 
and IID column so that the outliers can be removed during 
PLINK analysis with the ‘–remove’ command.
Conclusions
While the QC steps given here are not novel, this paper provides 
access to an automated process that both reduces human work time 
and chances for error and provides tools to make the computational 
experiment reproducible. It also gives recommended values for 
parameters but facilitates changing parameters and the comparison 
of effects.
Figure 3. Parameter files a) qc_params.txt b) pca_params.txt.
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Software availability
Zenodo: GWAS: Automated GWAS QC, doi: 10.5281/zen-
odo.5822811.
GitHub: https://github.com/sallyrose0425/GWAS, https://github.
com/sallyrose0425/GWAS/blob/master/LICENSE 
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 Brad Chapman
Department of Biostatistics, Harvard Public School of Health, Boston, MA, USA
The authors describe a useful tool for performing automated quality control analysis of GWAS input data.
They provide a set of script written in Python and R that automate running plink and smartpca to check for
common issues with input data. This is a valuable contribution for documenting and automating the
processes involved with checking GWAS input data.
I have some suggestions for improving the usefulness of the tool:
A description of the input data would help users get started with this tool. Does it take only array
genotyping data or also sequencing data? Is different pre-processing or QC threshold adjustment
required for the different types of data?
 
The software needs a minimal set of example files that users can run to confirm they have the
necessary system tools installed. This will help distinguish errors in installation/running from errors
in the input data. It will also help users understand the exact inputs, including plink phenotype files.
It's quite hard to get started with any tool without test data. If you run into issues it is hard to
distinguish differences/problems with your dataset from issues with the code.
 
It would be helpful for tool usage if it had a unique name. Naming the scripts generically as GWAS
(or GWAS QC) makes it hard to reference or find information about the tool.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
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Title and abstract: The title and abstract are appropriate and suitably summarize the work.
 
 The article describes a series of scripts that the authors have developed to provideArticle content:
quality control measures for genomewide association studies The scripts address critical questions for
genomewide association study datasets such as checking the extent of heterozygosity to determine
whether it is as expected, checking whether there are markers that do not follow Hardy-Weinberg
equilibrium predictions, and checking whether there are pairs of closely related individuals. The authors
provide a helpful series of scripts that will allow users to perform these tasks in a reproducible and
automated fashion. The scripts make it easy to determine the number of samples removed for different
parameter settings. These scripts are likely to be valuable for researchers in the field.
 
 The conclusions of the manuscript are appropriate, that use of these scripts will allow forConclusions:
consistent quality control of genomewide association study datasets, which will lead to better
interpretation of the available data.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
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The current manuscript by Ellingson is regarding the automation of the quality control (QC) ofet al., 
genome wide association studies (GWAS). Automation is important as it reduces human errors and
increases work efficiency. In this manuscript authors have written a python script that automates the
process of QC of GWAS data. The QC steps in this pipeline follow the notes developed by MikeWeale et
al.
However, there are some issues with the current version of the manuscript.
There is/are already software like QCGWAS , which are automated for QC of GWAS. So how is
the current version of the software different or better from the already existing softwares. So
authors should try to summarize by comparing in terms of efficiency, accuracy in performance of
their work with the already present softwares in this field.
 
Authors should provide a link to a test dataset that can be used to check if the required softwares
are installed and running properly.
 
The introduction should be carefully written citing the known automated softwares for GWAS. 
Overall the current version of manuscript the authors have failed to bring the uniqueness of their work in
the field .
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